Cash flows from operating activities: | |
Net income | 49.48M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation | 127.18M |
Amortization | |
Loss on foreign currency exchange | |
Mark to market adjustment on derivative contracts | |
Excess tax (benefits) deficiency from stock-based compensation | |
Stock-based compensation | 22.78M |
Loss on disposition of assets, net | 2.05M |
Write-down of tangible assets | |
Deferred income taxes | -1.63M |
Curtailment of postretirement benefit obligation | |
Other | -2.79M |
Changes in operating assets and liabilities, net of acquisitions: | |
Receivables | -16.83M |
Inventories | -8.14M |
Prepaid expenses and other assets | -31.2M |
Accounts payable, accrued expenses and other liabilities | 86.82M |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Additions to property, plant and equipment | -131.94M |
Additions to other intangible assets | -10.9M |
Acquisition of business, net of cash acquired | -2.64B |
Proceeds from sale of fixed assets | 1.47M |
Net cash used in investing activities | |
Cash flows from financing activities: | |
Proceeds from issuance of debt | 1.03B |
Borrowings under revolving credit facility | 239.3M |
Payments under revolving credit facility | -313.3M |
Payments on capitalized lease obligations | |
Proceeds from issuance of common stock, net of expenses | 835.13M |
Payment of deferred financing costs | -34.33M |
Net (payments) proceeds related to stock-based award activities | -1.05M |
Excess tax benefits (deficiency) from stock-based compensation | |
Net cash (used in) provided by financing activities | |
Effect of exchange rate changes on cash and cash equivalents | 3.86M |
Net (decrease) increase in cash and cash equivalents | 12.31M |
Cash and cash equivalents, beginning of period | |
Cash and cash equivalents, end of period |